Search For "drugs control"
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 5 years ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step c
Updated : 5 years ago IST
New Delhi [India], June 2 (ANI): The Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other international regulatory bodies - a big move likely to clear the way for foreign vaccines like Pfizer and Moderna for the
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 5 years ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
Karnataka: BJP youth wing demands action against Congress youth wing for i
Updated : 5 years ago IST
Bengaluru (Karnataka) [India], May 18 (ANI): BJP youth wing in Bengaluru in a letter to state drugs controller demanded action against Congress youth wing Karnataka president MS Raksha Ramaiah and other workers alleging that they are issuing medicine kits containing drugs that can be sold
Read More
DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to
Updated : 5 years ago IST
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
Read More
DRDO's anti-COVID 2-DG drug effective against different variants: DRDO sci
Updated : 5 years, 1 month ago IST
New Delhi [India], May 8 (ANI): The Defence Research and Development Organisation (DRDO)'s new anti-COVID drug, just approved by the Drugs Controller General of India (DCGI) is effective against different variants of the coronavirus and helps in bringing patients out of oxygen support, sa
Read More
DCGI nods anti-COVID drug developed by DRDO for emergency use
Updated : 5 years, 1 month ago IST
New Delhi [India], May 8 (ANI): The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-COVID drug - 2-deoxy-D-glucose (2-DG) - as an adjunct therapy in moderate to severe COVID-19 cases.
Read More
VINS Bioproducts gets DCGI nod to commence clinical trials for VINCOV-19
Updated : 5 years, 1 month ago IST
Hyderabad (Telangana) [India], April 26 (ANI): VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19, the Hyderabad based immunological company said.
Read More
DGCI approves emergency use of Zydus's Virafin in treating moderate COVID-
Updated : 5 years, 1 month ago IST
New Delhi [India], April 23 (ANI): Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the use of 'Virafin', Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
Read More
Zydus' Virafin gets emergency use approval for treating moderate COVID-19
Updated : 5 years, 1 month ago IST
New Delhi [India], April 23 (ANI): The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.
Read More
Delhi govt sets up two control rooms to counter shortage of COVID-19 manag
Updated : 5 years, 1 month ago IST
New Delhi [India], April 19 (ANI): The Drugs Control Department of the Delhi government has set up two control rooms to counter the shortage of COVID-19 management drugs, the Chief Minister Office (CMO) said on Monday.
Read More
Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 trea
Updated : 5 years, 2 months ago IST
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
Read More